Proteomics analysis in rats reveals convergent mechanisms between major depressive disorder and dietary zinc deficiency

被引:0
|
作者
Gasior, Lukasz [1 ]
Pochwat, Bartlomiej [1 ]
Zareba-Koziol, Monika [2 ]
Wlodarczyk, Jakub [2 ]
Grabrucker, Andreas Martin [3 ,4 ,5 ]
Szewczyk, Bernadeta [1 ]
机构
[1] Polish Acad Sci, Maj Inst Pharmacol, Dept Neurobiol, Smetna 12, PL-31343 Krakow, Poland
[2] Polish Acad Sci, Nencki Inst Expt Biol, Lab Cell Biophys, Ludw Pasteura 3, PL-02093 Warsaw, Poland
[3] Univ Limerick, Dept Biol Sci, Limerick V94PH61, Ireland
[4] Univ Limerick, Bernal Inst, Limerick V94PH61, Ireland
[5] Univ Limerick, Hlth Res Inst HRI, Limerick V94PH61, Ireland
关键词
Depression; Zinc deficiency; Mitochondrial dysfunction; Proteomic analysis; MITOCHONDRIAL RESPIRATORY-CHAIN; PREFRONTAL CORTEX; OXIDATIVE STRESS; MODEL; HIPPOCAMPUS; TRANSPORTER; MODULATION; BEHAVIOR; INHIBITION; ACTIVATION;
D O I
10.1007/s43440-024-00681-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Preclinical and clinical studies have shown that dietary zinc deficiency can lead to symptoms similar to those observed in major depressive disorder (MDD). However, the underlying molecular mechanisms remain unclear. To investigate these mechanisms, we examined proteomic changes in the prefrontal cortex (PFC) and hippocampus (HP) of rats, two critical brain regions implicated in the pathophysiology of depression. Methods Rats were fed diets either adequate in zinc (ZnA, 50 mg Zn/kg) or deficient in zinc (ZnD, <3 mg/kg) for four weeks. High-throughput proteomic analysis was used to detect changes in protein expression, supplemented by enzyme activity assay for mitochondrial complexes I and IV, examining their functional impacts. Results ZnD led to significant alterations in protein expression related to zinc transport and mitochondrial function. Proteomic analysis revealed changes in zinc transporter family members such as Slc30a1 (6.64 log2FC), Slc30a3 (-2.32 log2FC), Slc30a4 (2.87 log2FC), Slc30a5 (5.90 log2FC), Slc30a6 (1.50 log2FC), and Slc30a7 (2.17 log2FC) in the PFC, and Slc30a3 (-1.02 log2FC), Slc30a5 (-1.04 log2FC), and Slc30a7 (1.08 log2FC) in the HP of rats subjected to ZnD. Furthermore, ZnD significantly affected essential mitochondrial activity proteins, including Atp5pb (3.25 log2FC), Cox2 (2.28 log2FC), Atp5me (2.04 log2FC), Cyc1 (2.30 log2FC), Cox4i1 (1.23 log2FC), Cox7c (1.63 log2FC), and Cisd1 (1.55 log2FC), with a pronounced decrease in complex I activity in the PFC. Conclusions Our study demonstrates that ZnD leads to significant proteomic changes in the PFC and HP of rats. Specifically, ZnD alters the expression of zinc transporter proteins and proteins critical for mitochondrial function. The significant decrease in complex I activity in the PFC further underscores the impact of ZnD on mitochondrial function. These results highlight the molecular mechanisms by which ZnD can influence brain function and contribute to symptoms similar to those observed in depression.
引用
收藏
页码:145 / 157
页数:13
相关论文
共 50 条
  • [1] Proteomic analysis reveals changes in the hippocampus protein pattern of rats exposed to dietary zinc deficiency
    Liu, Jing
    Jiang, Yugang
    Huang, Chengyu
    Fang, Hongyun
    Fang, Hengtong
    Pang, Wei
    ELECTROPHORESIS, 2010, 31 (08) : 1302 - 1310
  • [2] Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder
    Reus, Gislaine Z.
    dos Santos, Maria Augusta B.
    Strassi, Ana Paula
    Abelaira, Helena M.
    Ceretta, Luciane B.
    Quevedo, Joao
    LIFE SCIENCES, 2017, 183 : 78 - 82
  • [3] Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysis
    Saberi, Amin
    Ebneabbasi, Amir
    Rahimi, Sama
    Sarebannejad, Sara
    Sen, Zumrut Duygu
    Graf, Heiko
    Walter, Martin
    Sorg, Christian
    Camilleri, Julia A.
    Laird, Angela R.
    Fox, Peter T.
    Valk, Sofie L.
    Eickhoff, Simon B.
    Tahmasian, Masoud
    MOLECULAR PSYCHIATRY, 2025, 30 (02) : 736 - 751
  • [4] Influences between defense mechanisms and antidepressants on the therapeutic compliance in major depressive disorder
    Vasile, D.
    Vasiliu, O.
    Vasile, M. L.
    Terpan, M.
    Mangalagiu, A.
    Bogdan, V.
    Ojog, D.
    Petrescu, M. B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S343 - S344
  • [5] GWAS Meta-Analysis Reveals Shared Genes and Biological Pathways between Major Depressive Disorder and Insomnia
    Lin, Yi-Sian
    Wang, Chia-Chun
    Chen, Cho-Yi
    GENES, 2021, 12 (10)
  • [6] Single-nucleus transcriptomic analysis reveals the relationship between gene expression in oligodendrocyte lineage and major depressive disorder
    Xie, Yinping
    Chen, Lijuan
    Wang, Leimin
    Liu, Tongou
    Zheng, Yage
    Si, Lujia
    Ge, Hailong
    Xu, Hong
    Xiao, Ling
    Wang, Gaohua
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [7] Single-nucleus transcriptomic analysis reveals the relationship between gene expression in oligodendrocyte lineage and major depressive disorder
    Yinping Xie
    Lijuan Chen
    Leimin Wang
    Tongou Liu
    Yage Zheng
    Lujia Si
    Hailong Ge
    Hong Xu
    Ling Xiao
    Gaohua Wang
    Journal of Translational Medicine, 22
  • [8] Zinc, C-reactive protein, and cortisol in major depressive disorder: an exploratory analysis
    Cubala, Wieslaw Jerzy
    Landowski, Jerzy
    Dziadziuszko, Malgorzata
    Chrzanowska, Anna
    Wielgomas, Bartosz
    TRACE ELEMENTS AND ELECTROLYTES, 2017, 34 (03) : 104 - 106
  • [9] Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study
    Mesleh, Areej
    Ehtewish, Hanan
    de la Fuente, Alberto
    Al-shamari, Hawra
    Ghazal, Iman
    Al-Faraj, Fatema
    Al-Shaban, Fouad
    Abdesselem, Houari B.
    Emara, Mohamed
    Alajez, Nehad M.
    Arredouani, Abdelilah
    Decock, Julie
    Albagha, Omar
    Stanton, Lawrence W.
    Abdulla, Sara A.
    El-Agnaf, Omar M. A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [10] Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis
    Cakici, Nuray
    Bot, Mariska
    Lamers, Femke
    Janssen, Thomas
    van der Spek, Peter J.
    de Haan, Lieuwe
    Bahn, Sabine
    Penninx, Brenda W. J. H.
    van Beveren, Nico J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (07) : 835 - 846